Wang, Y.; Wu, F.; Yang, T.; Li, B.; Wang, H.; Ye, P.; Li, W.
Dual-Action Tocilizumab-Conjugated Cisplatin Nanoparticles Overcome Chemoresistance and Metastasis in Non-Small-Cell Lung Cancer. Pharmaceutics 2025, 17, 945.
https://doi.org/10.3390/pharmaceutics17070945
AMA Style
Wang Y, Wu F, Yang T, Li B, Wang H, Ye P, Li W.
Dual-Action Tocilizumab-Conjugated Cisplatin Nanoparticles Overcome Chemoresistance and Metastasis in Non-Small-Cell Lung Cancer. Pharmaceutics. 2025; 17(7):945.
https://doi.org/10.3390/pharmaceutics17070945
Chicago/Turabian Style
Wang, Yin, Fanyu Wu, Tan Yang, Bin Li, Han Wang, Peng Ye, and Weijie Li.
2025. "Dual-Action Tocilizumab-Conjugated Cisplatin Nanoparticles Overcome Chemoresistance and Metastasis in Non-Small-Cell Lung Cancer" Pharmaceutics 17, no. 7: 945.
https://doi.org/10.3390/pharmaceutics17070945
APA Style
Wang, Y., Wu, F., Yang, T., Li, B., Wang, H., Ye, P., & Li, W.
(2025). Dual-Action Tocilizumab-Conjugated Cisplatin Nanoparticles Overcome Chemoresistance and Metastasis in Non-Small-Cell Lung Cancer. Pharmaceutics, 17(7), 945.
https://doi.org/10.3390/pharmaceutics17070945